- Saliva sample collection is an easy, non-invasive and convenient testing experience for patients who can self-collect their saliva sample. - Roche continues to develop testing options
Roche receives FDA authorisation for testing of asymptomatic people with the cobas SARS-CoV-2 Test to help control the spread of COVID-19
The high-throughput, highly sensitive cobas SARS-CoV-2 Test under FDA Emergency Use Authorisation can now be used to test individual or pooled samples from people without symptoms or other reasons to suspect COVID-19
Accurate, reliable and early detection of SARS-CoV-2 in potentially exposed individuals can help limit the spread of disease
PLEASANTON, Calif., May 18, 2021 /PRNewswire/ Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its
cobas SARS-CoV-2 Test for use on the widely available, high-throughput
cobas 6800/8800 Systems has received Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA) for testing individuals without symptoms or reasons to suspect COVID-19. This authorisation supports the guidance update from the U.S. Centers for Disease Control and Prevention (CDC) to expand SARS-CoV
Is it COVID or the flu? New combo tests can find out
By Roxanne Khamsi New York Times,Updated May 11, 2021, 8:15 a.m.
Email to a Friend
A person was tested for COVID at a site in Randolph. New tests can detect not only the coronavirus, but two types of influenza and the respiratory syncytial virus, or RSV.Craig F. Walker/Globe Staff
In January, a man in his 60s with heart disease and diabetes went to a South Dakota hospital with a cough and fever, worried he had COVID. A nurse swabbed the inside of his nose, and the sample went into a small device resembling an inkjet-printer cartridge, which was then placed into a machine about the size of a printer.